Molecular pathogen detection
Ended Awarded Last action
- Contract number
- 36C24824N0202
- Awardee
-
Biofire Diagnostics LLC UEI TBBNREFT3LD3
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $1,265,432
Award facts
- Contract value 100% obligated
- $1,265,432.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Emigration Canyon, UT 84108, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$45,124 | |
| Other Administrative Action | -$21,209 | |
| Other Administrative Action | -$134,535 | |
| Original award | $1,466,301 |
About this award
Biofire Diagnostics LLC received a $1.27 million firm fixed-price BPA call award from the Department of Veterans Affairs' Veterans Integrated Service Network 8 for molecular pathogen detection services. The contract was awarded on November 29, 2023, with an ultimate completion date of September 30, 2024, and will be performed in Emigration Canyon, Utah. This award represents a task order against Biofire's existing General Services Administration Federal Supply Schedule contract (FSS-65-VII) for in vitro diagnostics, reagents, and tests. The company did not utilize any set-aside designation to secure this award, reflecting its competitive positioning in the federal diagnostic products marketplace.
Biofire Diagnostics specializes in molecular diagnostic testing solutions, particularly syndromic infectious disease detection systems including its FilmArray diagnostic platform and associated reagents. The VA and its various Veterans Integrated Service Networks have established this company as a key supplier of diagnostic capabilities across respiratory, gastrointestinal, bloodstream infection, and meningitis testing. This procurement aligns with the VA's broader healthcare delivery mission and represents one of multiple BPA vehicles Biofire has established across federal agencies including the Indian Health Service and Defense Health Agency, enabling cost-effective on-demand procurement of critical diagnostic products and services.
Quick answers
Who was awarded contract 36C24824N0202?
36C24824N0202 was awarded to Biofire Diagnostics LLC by Veterans Integrated Service Network 8 (Veterans Health Administration) on November 29, 2023.
How much is contract 36C24824N0202 worth?
The government has obligated $1,265,432 on 36C24824N0202.
Is contract 36C24824N0202 an order under another contract?
Yes. 36C24824N0202 is a BPA call under V797D30085-36C24820A0028, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C24824N0202 competed?
The extent of competition for 36C24824N0202 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award